120 related articles for article (PubMed ID: 38684043)
1. Comparison of Comorbidity Models Within a Population-Based Cohort of Older Adults With Non-Hodgkin Lymphoma.
Gordon MJ; Duan Z; Zhao H; Nastoupil L; Iyer S; Ferrajoli A; Danilov AV; Giordano SH
JCO Clin Cancer Inform; 2024 Apr; 8():e2300223. PubMed ID: 38684043
[TBL] [Abstract][Full Text] [Related]
2. A novel comorbidity score for older adults with non-Hodgkin lymphoma: the 3-factor risk estimate scale.
Gordon MJ; Duan Z; Zhao H; Nastoupil L; Ferrajoli A; Danilov AV; Giordano SH
Blood Adv; 2023 Jun; 7(11):2632-2642. PubMed ID: 36753602
[TBL] [Abstract][Full Text] [Related]
3. Cause-specific mortality among Medicare beneficiaries with newly diagnosed non-Hodgkin lymphoma subtypes.
Hester LL; Park SI; Wood WA; Stürmer T; Brookhart MA; Lund JL
Cancer; 2019 Apr; 125(7):1101-1112. PubMed ID: 30548238
[TBL] [Abstract][Full Text] [Related]
4. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
Milano AF
J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
Abuamsha H; Kadri AN; Hernandez AV
Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Evaluation of Medical Conditions Associated with Risk of Non-Hodgkin Lymphoma using Medicare Claims ("MedWAS").
Engels EA; Parsons R; Besson C; Morton LM; Enewold L; Ricker W; Yanik EL; Arem H; Austin AA; Pfeiffer RM
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1105-13. PubMed ID: 27197296
[TBL] [Abstract][Full Text] [Related]
7. The impact of comorbidity on overall survival in elderly nasopharyngeal carcinoma patients: a National Cancer Data Base analysis.
Huang Y; Chen W; Haque W; Verma V; Xing Y; Teh BS; Brian Butler E
Cancer Med; 2018 Apr; 7(4):1093-1101. PubMed ID: 29493889
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221
[TBL] [Abstract][Full Text] [Related]
9. Risk and outcome of non-Hodgkin lymphoma among classical Hodgkin lymphoma survivors.
Xavier AC; Armeson KE; Hill EG; Costa LJ
Cancer; 2013 Sep; 119(18):3385-92. PubMed ID: 23797978
[TBL] [Abstract][Full Text] [Related]
10. Incidence and survival of second primary non-Hodgkin lymphoma: A Surveillance, Epidemiology, and End Results-based cohort study.
Yu N; Zhang W; Zhong X; Song X; Li W
PLoS One; 2024; 19(3):e0300330. PubMed ID: 38466704
[TBL] [Abstract][Full Text] [Related]
11. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
Kato I; Booza J; Quarshie WO; Schwartz K
J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
[TBL] [Abstract][Full Text] [Related]
12. Causes of mortality in cases with extra nodal natural killer/T-cell lymphoma, nasal type: A cohort study.
Mei M; Wang Y; Zhang M
PLoS One; 2019; 14(4):e0214860. PubMed ID: 30995261
[TBL] [Abstract][Full Text] [Related]
13. Differences in non-Hodgkin lymphoma survival between young adults and children.
Tai E; Pollack LA; Townsend J; Li J; Steele CB; Richardson LC
Arch Pediatr Adolesc Med; 2010 Mar; 164(3):218-24. PubMed ID: 20194253
[TBL] [Abstract][Full Text] [Related]
14. Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma.
Cerhan JR; Bernstein L; Severson RK; Davis S; Colt JS; Blair A; Hartge P
Cancer Causes Control; 2005 Dec; 16(10):1203-14. PubMed ID: 16215871
[TBL] [Abstract][Full Text] [Related]
15. Hospice Use Among Patients With Lymphoma: Impact of Disease Aggressiveness and Curability.
Odejide OO; Cronin AM; Earle CC; LaCasce AS; Abel GA
J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26438575
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of serum beta-2 microglobulin in patients with non-Hodgkin lymphoma.
Wu L; Wang T; Gui W; Lin H; Xie K; Wang H; Gao T; Zhang X; Liu L; Han T; Tian Y; Hou L
Oncology; 2014; 87(1):40-7. PubMed ID: 24969158
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Environmental Chemical Mixtures and Non-Hodgkin Lymphoma Risk in the NCI-SEER NHL Study.
Czarnota J; Gennings C; Colt JS; De Roos AJ; Cerhan JR; Severson RK; Hartge P; Ward MH; Wheeler DC
Environ Health Perspect; 2015 Oct; 123(10):965-70. PubMed ID: 25748701
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database.
Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM
Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406
[TBL] [Abstract][Full Text] [Related]
19. Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection.
Ulcickas Yood M; Quesenberry CP; Guo D; Caldwell C; Wells K; Shan J; Sanders L; Skovron ML; Iloeje U; Manos MM
Hepatology; 2007 Jul; 46(1):107-12. PubMed ID: 17526021
[TBL] [Abstract][Full Text] [Related]
20. Characterizing Lymphoma Incidence and Disparities for a Cancer Center Catchment Region.
Ayers AA; Lyu L; Dance K; Ward KC; Flowers CR; Koff JL; McCullough LE
Clin Lymphoma Myeloma Leuk; 2019 Nov; 19(11):699-708.e5. PubMed ID: 31494062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
